Endo Announces Peyronie’s Disease Presentation at the SurgeWest Annual Meeting of the Western Section of the American Urological Association
MALVERN, Pa., Oct. 25, 2024 /PRNewswire/ -- Endo, Inc. announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or CCH)